BMC’s Yawkey building doors are now closed as an entrance as part of our ongoing efforts to enhance our campus and provide you with the best clinical care.

All patients and visitors on our main campus must enter our hospital via Shapiro, Menino, or Moakley buildings, where they will be greeted by team members at a new centralized check-in desk before continuing to the hospital. We are excited to welcome you and appreciate your patience as we improve our facilities.

Sobre

Salant is Professor of Medicine and Vice-Chair for Research. He received his medical degree from University of the Witwatersrand in South Africa and completed his clinical training at the Johannesburg Hospital. He received his research training at Boston University with Dr. William G. Couser and joined BU’s nephrology faculty in 1979. Dr. Salant is an internationally renowned physician-scientist and an acclaimed educator. His research primarily explores the immune basis for glomerular diseases and the mechanisms of podocyte injury. He was among the first to identify podocytes as the primary target of injury in antibody-mediated glomerular diseases. In a landmark New England Journal of Medicine paper in 2009, Drs. Salant, Beck and colleagues described their discovery of the target antigen in membranous nephropathy and showed that a high proportion of MN patients have circulating autoantibodies to the antigen on human podocytes. Dr. Salant is a past chairman of the ABIM Nephrology Board.

  • Administrative Title

    Vice Chair for Research, Professor of Pathology and Laboratory Medicine, Boston University Chobanian and Avedisian School of Medicine

  • Residency

    Johannesburg Hospital, 1970-1974
  • Fellowship

    Boston University School of Medicine (Research) 1977-1979
  • Education

    University of Witwatersrand, South Africa, 1969